Placenta-Derived Decidua Stromal Cells for Hemorrhagic Cystitis after Stem Cell Transplantation | Zendy

Wictor Aronsson-Kurttila | Zendy; Arjang Baygan | Zendy; Gianluca Moretti | Zendy; Mats Remberger | Zendy; Bita Khoein | Zendy; Guido Moll | Zendy; Behnam Sadeghi | Zendy; Olle Ringdén | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Placenta-Derived Decidua Stromal Cells for Hemorrhagic Cystitis after Stem Cell Transplantation

Author(s) -

Wictor Aronsson-Kurttila,

Arjang Baygan,

Gianluca Moretti,

Mats Remberger,

Bita Khoein,

Guido Moll,

Behnam Sadeghi,

Olle Ringdén

Publication year - 2018

Publication title -

acta haematologica

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.574

H-Index - 56

eISSN - 1421-9662

pISSN - 0001-5792

DOI - 10.1159/000485735

Subject(s) - decidua , stromal cell , transplantation , stem cell , placenta , medicine , hemorrhagic cystitis , immunology , biology , pathology , pregnancy , hematopoietic stem cell transplantation , fetus , microbiology and biotechnology , genetics

Hemorrhagic cystitis (HC) is a serious complication after hematopoietic stem cell transplantation (HSCT). Stromal cells have been tested as therapy for HC. Decidua stromal cells (DSCs) protect the fetus from the mother's immune system.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research